Lonnie Howell has held multiple executive positions in the banking and investment sector since the late 1970s, most recently as Chief Executive Officer of EFG International, a listed bank holding company. 

From 1995 to 1997, Lawrence was CEO of the predecessor entity, EFG Bank, and Chief Executive Officer of EFG Bank Zurich from 1997 to 2005. Lonnie was also with Coutts & Co. International Private Banking from 1989 until 1995, where he was Head of Americas based in New York and responsible for clients domiciled in the Americas as well as for the bank’s offices in the USA, the Bahamas, Bermuda, Cayman Islands and Latin America. Prior to 1993, he was Head of Americas and Asia in Zurich and New York. From 1986 to 1989, Lawrence spent three years at Citibank Switzerland as Vice President in charge of Swiss Ultra High Net Worth clients. From 1985 to 1986 he was with McKinsey & Co. in New York consulting on insurance, retail banking and private banking.

Lonnie embarked his career at Citibank in 1978 as internal legal counsel for the International Private Banking Division. Thereafter, from 1981 to 1984 he was Chief of Staff for the Head of Private Banking for Europe, Middle East and Africa (JP Cuoni).

Holdings: 8,690,980 shares held by spouse Karin Howell-Bidermann.

Independent: Independent in relation to the Company and its management, but not in relation to major shareholders.



Magnus Hardmeier is the Managing Director of Priveq Investment, a leading Swedish private equity investor, and an investor in Mentice AB since 2005. He has accumulated more than 20 years of venture capital and private equity business experience. Prior to joining Priveq Investment in 1987, Magnus worked in the financial department at Wallenius and spent three years with the Swedish venture capital company Företagskapital.

Magnus has been actively involved in a number of different business sectors, with a particular focus on medical technology and high-tech product companies. Investments include Jostra, Hörnell, Novaseptic and M2 Engineering.  

Magnus holds a degree from the Stockholm School of Economics and did MBA level studies at McGill University, Canada.

Holdings: -

Independent: Independent in relation to the Company and its management, but not in relation to major shareholders, as a representative for Priveq Investment, the Company’s second largest shareholder.

Bengt (2)


Bengt Sjöholm has long experience from the Medtech industry, essentially within the pharmaceutical and hospital sectors. Bengt held leading positions in the Getinge Group, being a part of the group management for more than 10 years. He was also CEO of Tylö group, a company within the wellness business and Movement Medical AB, an orthopedic hospital, now a part of the Capio group.

Bengt is currently involved in creating a new concept for hospital management, Hälsostaden.

Holdings: 15,000 shares held indirectly through company.

Independent: Independent in relation to the Company and its management, and in relation to major shareholders.



Johann Koss is an internationally recognized social entrepreneur who has been widely acknowledged for his work in promoting the use of sport and play as a tool for positive childhood development. He founded Right To Play in 2000, dedicating himself to growing it into an influential international non-government organization and a leader in the Sport for Development and Peace movement. Currently, the organization operates in more than 20 countries reaching over one million children each week, and has of 2014 had an annual budget of $48 million. The organization is supported by 650 staff worldwide and 16,000 volunteer Coaches.

Johann has received a number of awards for his philanthropic service and leadership. Most recently, he received the Order of Canada from the Governor General, the order is the cornerstone of the Canadian Honours System, recognizes outstanding achievement, dedication to the community and service to the nation. Before founding Right To Play, Johann was an Olympic speed skater and is considered to be one of the greatest winter Olympians of all time.  In 1994 he made world headlines when he won three gold medals in the Lillehammer Olympic Games, in his home country of Norway. 

Holding an undergraduate medical degree from the University of Queensland, and an Executive MBA from the Joseph L. Rotman School of Management, at the University of Toronto. He has received honorary degrees from Brock University, the University of Calgary, the Vrije Universiteit Brussels, the University of Aust Agder in Norway and most recently the University of Guelph-Humber.

Holdings: –

Independent: Independent in relation to the Company and its management, and in relation to major shareholders.




A board-certified internist, David J. Ballard, M.D., M.S.P.H., Ph.D., F.A.C.P., trained at the Mayo Clinic following completion of undergraduate degrees in chemistry and economics and graduate degrees in epidemiology (M.S.P.H and Ph.D.) and in medicine from the University of North Carolina (UNC) where he was a Morehead Scholar, North Carolina Fellow and junior year Phi Beta Kappa inductee. He is currently pursuing an MBA at the UNC Kenan-Flagler Business School. 

Professional Background: 

David is a global healthcare executive with demonstrated abilities for improving healthcare value and organizational financial performance while providing international thought leadership. 

Prior to joining Mentice, David was Consultant and founding Head of the Mayo Section of Health Services Evaluation, Professor of Medicine and Epidemiology at Emory University and Senior Vice President and Chief Quality Officer of Baylor Scott and White Health, the largest health care system in Texas.

He has been recognized by Becker’s Hospital Review annually over the past 4 years as one of 50 experts leading the field of patient safety and is a past President of the International Society for Quality in Health Care. Widely recognized as a global scholar in health care quality and value, his two books on healthcare quality leadership received Shingo Awards for their contributions to operational excellence in healthcare.

He received in 2008 the Distinguished Alumnus Award of the UNC School of Medicine and the corresponding recognition in 2019 of the UNC Gillings School of Global Public Health. He served for a decade on the boards of Baylor Scott and White The Heart Hospital, a highly innovative health care system-physician joint venture hospital and of the Baylor Scott and White Health and Select Medical long-term care and rehabilitation services joint venture.

He currently serves as an Executive Advisor for AlertMD, a health care analytics and artificial intelligence company with a mission to increase customer loyalty and efficiency across health care systems and is a member of the UNC Chancellor’s Global Leadership Council. 

Holdings: 33,928 shares and 238,320 warrants.

Independent: Independent in relation to the Company and its management, and in relation to major shareholders.


Denis Gestin

Denis Gestin has over 30 years of experience in the management and commercial development of medical technologies companies. 

He began his career at Ela Medical Inc. (Livanova), and later joined St. Jude Medical where he most recently was President of the International Division (OUS) and was instrumental in the development of the company from $600 million to close to $6 billion. He then became Senior Vice President of Global Commercial Integration after the merger with Abbott Laboratories.

Denis serves as Chairman of the board in Holistick Medical, France, and Endo Tools Therapeutics and board member of CathVision. He is a graduate of EDC Paris Business School.

Holdings: -

Independent: Independent in relation to the company, its management and major shareholders.


Gösta Johannesson

Gösta Johannesson, is Senior Advisor at Bure Equity. Gösta has been working with investments more than 20 years. Prior to Bure, Gösta was a Partner at Provider Partners between 2000-2013 were he negotiated and completed several M&A deals and financing rounds. He has also held several senior positions at Öhman Fondkommission and Handelsbanken Markets.

Gösta has a broad experience of different industries and has been board member in several companies. He is currently chairman of the board of XVIVO Perfusion, deputy chairman of Interflora and Axiell Group, board member of Yubico, Scandinova and others.

Gösta holds a B.Sc in Business Administration and Economics at Uppsala University and AMP at Wharton business school.

Holdings: 10,000 shares held indirectly through company.

Independent: Independent in relation to the company, its management but not in relation to one major shareholder.

Subscribe to Email Updates